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Summary 
Some imines and azo compounds containing furoxan and benzene rings has been prepared 
starting from 4-(2-amino-3,4-dimethoxyphenyl)-3-methylfuroxan. The structure of reported 
compounds has been confirmed by UV, IR, a NMR spectroscopy.  
 
I - Introduction 
The furoxan derivatives have been shown to 
possess pharmacological activities. Some are 
depressants of the central nervous system, or of 
frog flesor muscle reflexes, or are reported as 
potential antitrypanosomal drugs [1], hypoxic 
cytotoxins [2, 3], vasodilatory activities [4 - 7]. 
These compounds have been shown to possess 
NO - mimetic pharmacological activities [8, 9]. 
In previous paper [10] we reported on the 
preparation and structure of 4-(2-amino-3,4-
dimethoxyphenyl)-3-methylfuroxan starting 
from eugenol, herein some imines and azo 
compounds  derived from this  amine are 
described. 
II - Experiment 
1. Physical measurements 
IR spectra were recorded on a IMPACK- 
410 NICOLET spectrometer in KBr discs at 400 
÷ 4000 cm-1. 
The UV spectra are recorded in ethanol at 
concentration 10-4 – 10-5 M using UV-Vis 
Cintra spectrometer. 
NMR spectra were recorded on Bruker 
AVANCE 500 MHz spectrometer, all at 298 ÷ 
300 K, in d6-DMSO with TMS as the internal 
standard.  
2. Preparation 
General procedure for the preparation of imines 
1 ÷  5 
A solution of 1 mmol of 4-(2-amino-3,4-
dimethoxyphenyl)- 3-methylfuroxan (Am)  and 
1 mmol of an  aromatic aldehyde dissolved in 
20 ml of ethanol was refluxed over 8-10 hours. 
The mixture was allowed to stand at room 
temperature. The resulting yellow precipitate 
was collected and recrystallized from etanol.  
The preparation of azo compounds 6 and 7 
4-(2-amino-3,4-dimethoxyphenyl)-3-
methylfuroxan (Am), 1 mmol  in 1 ml HCl 
(1:3), was diazotized by  1 ml of  1M NaNO2 
solution at 0oC . The obtained solution was 
added to a solution of 1.2 mmol of phenol 
compound in 3 ml 1.5 M NaOH solution at 0 - 
5oC. The resulting precipitate was collected and 
recrystallized from etanol: dioxane 1:1. 
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The preparation of azo compounds 8 and 9 
4-(2-amino-3,4-dimethoxyphenyl)-3-
methylfuroxan (Am), 1 mmol  in 1ml HCl (1:3), 
was diazotized by  1 ml of  1M NaNO2 solution 
at 0oC . The obtained solution was added to a 
solution of 1.2 mmol of aromatic amine in 3 ml 
1.5 M acetic acid solution at 0 - 5oC during 30 
minutes. After that, the mixture was heated at 
60 oC during 20 minutes and then allowed to 
stand at room temperature. The resulting 
precipitate was filtered with suction and 
recrystallized from etanol : dioxane 1:1.  
III - Results and discussion 
The imines have been prepared by 
condensation of 4-(2-amino-3,4-dimethoxy-
phenyl)- 3-methylfuroxan (Am) with aromatic 
aldehydes:
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Ar:  2-FC6H4(1); 2-NO2C6H4 (2); 2-HOC6H4 (3); 2,4-(HO)2C6H3 (4); 3-CH3O-4-HOC6H3  (5) 
 
The azo compounds have been synthesized as following: 
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0-5 oC
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CH3O
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Ar: 3-NO2-4-HOC6H3 (6); 4-HOC10H6 (4-hydroxynapht-1-yl) (7), 3-CH3-4-H2NC6H3 (8), 4-H2NC10H6   
(4-aminonapht-1-yl) (9) 
                
The obtained imines are yellow crystals, and the azo compounds are orange or red 
crystalline solids. The imine-derivatives (1 - 5) have a band in region near 338 - 358 nm (logε = 3.8 
- 4.6). The azo compounds (6 - 9) have bands in the visible region 393 - 455 nm (logε = 3.9 - 4.5) 
due to the azo chromophore. The main IR- absorption bands of the compounds are listed in Table 1. 
In  IR spectra of the examined compounds (table 1) there are several absorption bands at 
1480 - 1612 cm-1,  characterized  for C=N and C=C of imine group, benzene and furoxane ring. In 
spectra of 3-7 there is a broad O-H stretching band of phenol (~ 3400 cm-1). The spectra of 8, 9, 
each show a pair shape of N-H stretching bands of primary amine. 
The 1H NMR data of the examined compounds are listed in table 2. The assignment of the 
proton signals based on their spin-spin splitting patterns and on a comparison with proton signals of 
analogous compounds [10, 11]. The numeration of the examined compounds especially for analysis 
NMR spectra is shown as following: 
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Table 1: The yield, melting point and IR-absorption of the synthesized compounds 
IR, cm-1
Com. 
Yield 
% 
mp, oC νOH , νNH νCH νC=N , νC=C νNO
1 69 155 - 156 - 3076, 2999, 2966 1612, 1550, 1496 1453 
2 80 220 - 221 - 3067, 3002, 2938 1603, 1523, 1492 1446 
3 70 194 3400 3002, 2945, 2845 1607, 1532, 1496 1454 
4 70 208.5 - 209 3433, 3353 3010, 2938, 2845 1607, 1550, 1496 1449 
5 20 190 - 191 3454, 3354 3060, 2988, 2945 1596, 1520, 1490 1450 
6 76 192 -193 3448 3i20, 2940, 2843 1604, 1528, 1490 1459 
7 79 196 - 197 3447 3088, 3072, 2937 1609, 1525, 1488 1456 
8 80 200 - 201 3300, 3254 3090, 3024, 2902 1601, 1517, 1491 1465 
9 85 194 -195 3379, 3240 3064, 3010, 2906 1597, 1505, 1489 1468 
 
Table 2: 1H NMR signals of examined compounds (δ, ppm; J, Hz) 
 1 2 3 4 5 8 
H3 7.18; s 7.19; s 7.21; s 7.16; s 7.14; s 7.16; s 
H6 7.28; s 7.20; s 7.40; s 7.33; s 7.18; s 7.27; s 
H7 3.94; s 3.91; s 3.95; s 3.94; s 3.92; s 3.92; s 
H7' 3.84; s 3.89; s 3.84; s 3.82; s 3.82; s 3.81; s 
H10 2.08; s 2.02; s 2.03; s 2.00; s 2.09; s 2.05; s 
H12 - - - - 7.34; d; 1.5 7.56; d;1.5 
H13 7.36; t; 
9.0 
8.04; dd; 
1.0; 8.0 
6.92; d; 
8.0 
6.26; d; 
2.2 
- - 
H14 7.59; ddd; 
7.5;6.5;1.5 
7.76; td; 
1.5; 8.0 
7.40; td; 
1.5; 8.0 
- - - 
H15 7.345; t; 
7.5 
7.85; t; 
8.0 
6.99; td; 
1.3; 7.5 
6.42; dd; 
2.5; 8.5 
6.89; d; 
8.5 
6.72; d; 
8.0 
H16 7.86; ddd; 
8.5;7.5;1.5 
7.98; dd; 
2,0; 8.0 
7.63; dd; 
1.5; 7.5 
7.43; d; 
8.5 
7.27; dd; 
1.5; 8.5 
7.56; dd; 
1.5; 8.5 
H17 8.94; s; 8.96; s; 9.09; s; 8.93; s; 8.64; s; - 
Other    12.8;s;(OH) 
10.3;s;(OH)
3.79; (OCH3) 2.14; (CH3) 
5.90; (NH2) 
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Gasco and colleges [12] showed that the 
chemical shift of a ring methyl group adjacent 
to the N-oxide oxygen of furoxans occurs at 
2.30 - 2.33 ppm, while a ring methyl group 
remote from it, at 2.50 - 2.53 ppm. The signal of 
the ring methyl group (H-10) of examined 
compounds appears as a singlet at 2.00 - 2.09 
ppm (Table 2) indicating that the methyl group 
is at position 3 of the furoxan ring.  
The 13C NMR spectra of compounds 4 and 5 
are recorded. The assignment of the 13C signals 
are based on their chemical shift and based on a 
comparison with 13C-NMR spectra of analogous 
compounds [10, 11].  The data are given in table 
3. 
For the imines 4 and 5, chemical shift of C1 
÷ C10 little changed from one to another, while 
chemical shift of C11 ÷ C17 are lager changed 
(table 3). 
   
Table 3: The 13C-NMR signals of imines 4 and 5 (δ, ppm) 
 Imine 4 Imine 5  Imine 4 Imine 5 
C1 151.77 151.83 C10 8.34 8.99 
C2 147.54 147.97 C11 134.38 127.70 
C3 112.72 112.62 C12 162.67 110.70 
C4 113.83 113.50 C13 102.35 147.30 
C5 140.28 142.83 C14 162.45 150.80 
C6 102.40 101.96 C15 108.12 115.61 
C7; C7' 55.98; 55.98 55.93; 55.88 C16 112.11 123.69 
C8 157.09 158.03 C17 162.07 159.56 
C9 112.90 114.29 Other - 55.32 
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